Zhejiang Orient Gene Biotech Co Ltd (688298) — Cash Flow-to-Debt Ratio
Zhejiang Orient Gene Biotech Co Ltd (688298) has a Cash Flow-to-Debt Ratio of -0.03x as of September 2025, meaning its operating cash flow of CN¥-30.52 Million could theoretically repay 0% of its total liabilities (CN¥1.01 Billion) in one year. Check Zhejiang Orient Gene Biotech Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Orient Gene Biotech Co Ltd Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Zhejiang Orient Gene Biotech Co Ltd across 9 annual periods. Also explore 688298 total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Zhejiang Orient Gene Biotech Co Ltd (2016–2024)
Year-by-year debt coverage analysis for Zhejiang Orient Gene Biotech Co Ltd. For market capitalisation and broader financial context, see Zhejiang Orient Gene Biotech Co Ltd (688298) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.27x | CN¥-348.33 Million | CN¥1.30 Billion | ▲ +75.9% |
| 2023 | -1.11x | CN¥-1.60 Billion | CN¥1.45 Billion | ▼ -188.0% |
| 2022 | 1.26x | CN¥3.00 Billion | CN¥2.38 Billion | ▼ -49.5% |
| 2021 | 2.49x | CN¥5.20 Billion | CN¥2.09 Billion | ▲ +56.2% |
| 2020 | 1.60x | CN¥1.79 Billion | CN¥1.12 Billion | ▲ +216.1% |
| 2019 | 0.50x | CN¥54.21 Million | CN¥107.38 Million | ▲ +47.6% |
| 2018 | 0.34x | CN¥44.33 Million | CN¥129.62 Million | ▲ +23.6% |
| 2017 | 0.28x | CN¥33.54 Million | CN¥121.20 Million | ▲ +233.5% |
| 2016 | 0.08x | CN¥11.81 Million | CN¥142.28 Million | — |